In the news · GLP-1 and weight-loss drugs

Is a bootleg weight-loss drug to blame for 2 reported deaths?

Headline from yahoo.com

CBS News, via Yahoo, reports the FDA received adverse event reports of two deaths, a 41-year-old woman and a 49-year-old patient, after using products claiming to be retatrutide, an unapproved Eli Lilly drug. The reports are unverified and causation is unclear. Poison centers logged 862 exposures in the three months ending in September, up from 460.

Why it matters: Relevant to Maryland adults exploring medical weight loss and to referring clinicians who field patient questions about unapproved weight-loss products sold online.

Read the full story at yahoo.com →

A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to yahoo.com. October 13, 2026.

AthleticsMD Clinical Desk

Today's front page

The newest articles and the day's news on GLP-1 & weight loss, Metabolic health, Hormones and more.

Go to the front page →